Notification

Divine Hira Jewellers IPO is Open!

Apply for the Divine Hira Jewellers IPO through UPI in just minutes.

Open a Free Demat Account

Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.

Trade Now, Pay Later with up to 4x

Never miss a good trading opportunity due to low funds with our MTF feature.

Track Market Movers Instantly

Stay updated with real-time data. Get insights at your fingertips.

NSE BSE

Trade Nowopens in a new tab

Wanbury Limited Share Price

₹ 226.21 7.04 (3.21%)

Mar 19 2025 03:30 PM Pharmaceuticals NSE: WANBURY

Wanbury Limited Share Price Update

As of the latest trading session, Wanbury Limited share price is currently at 226.21, which is up by 7.04 from its previous closing. Today, the stock has fluctuated between 220.20 and 232.00. Over the past year, Wanbury Limited has achieved a return of 67.94 %. In the last month alone, the return has been 11.86 %. Read More...

Wanbury Limited Performance

Day Range

Low220.20 High232.00

226.40

52 Week Range

Low 123.00 High 323.53

226.40

Wanbury Limited Share Price

14063

524212

WANBURY

Compare to down-arrow

View

Display

Studies

No Data Available

Open Price

227.00 Prev. Close

219.17 Volume (Shares)

137965.00

Total traded value

312.35 Upper Circuit

263.00 Lower Circuit

175.33

Note: The current prices & values are delayed, Loginopens in a new tab to your account for live updates.

Wanbury Limited Fundamentals

(Standalone)

Market Cap (Cr)	740.73
PE Ratio (TTM)	38.31
Book Value / Share	11.82
Beta	1.32

ROE	38.26%
EPS (TTM)	5.60
Dividend Yield	0.00%
Net Profit Qtr (Cr)	1.22

Wanbury Limited Financials

Key Results
Key Ratios
Balance sheet
Cash Flow
Competition

Revenue

Net income

Particulars	DEC 2024 (Values in Cr)
Revenue	133.45
Operating Expense	133.00
Net Profit	1.22
Net Profit Margin (%)	0.91
Earnings Per Share (EPS)	0.38
EBITDA	14.78
Effective Tax Rate (%)	5.42

Particulars	SEP 2024 (Values in Cr)
Revenue	161.19
Operating Expense	154.66
Net Profit	8.02
Net Profit Margin (%)	4.97
Earnings Per Share (EPS)	2.44
EBITDA	21.64
Effective Tax Rate (%)	1.83

Particulars	JUN 2024 (Values in Cr)
Revenue	131.11
Operating Expense	131.01
Net Profit	1.04
Net Profit Margin (%)	0.79
Earnings Per Share (EPS)	0.32
EBITDA	11.91
Effective Tax Rate (%)	0.00

Particulars	MAR 2024 (Values in Cr)
Revenue	139.41
Operating Expense	131.98
Net Profit	8.08
Net Profit Margin (%)	5.79
Earnings Per Share (EPS)	2.47
EBITDA	19.09
Effective Tax Rate (%)	3.23

Particulars	DEC 2023 (Values in Cr)
Revenue	145.50
Operating Expense	135.93
Net Profit	10.27
Net Profit Margin (%)	7.05
Earnings Per Share (EPS)	3.14
EBITDA	21.84
Effective Tax Rate (%)	-0.19

Particulars	MAR 2024 (Values in Cr)
Revenue	575.65
Operating Expense	547.85
Net Profit	30.40
Net Profit Margin (%)	5.28
Earnings Per Share (EPS)	9.29
EBITDA	72.99
Effective Tax Rate (%)	1.23

Particulars	MAR 2023 (Values in Cr)
Revenue	499.65
Operating Expense	510.25
Net Profit	-10.40
Net Profit Margin (%)	-2.08
Earnings Per Share (EPS)	-3.18
EBITDA	23.48
Effective Tax Rate (%)	-1.06

Particulars	MAR 2022 (Values in Cr)
Revenue	511.19
Operating Expense	507.93
Net Profit	81.47
Net Profit Margin (%)	15.93
Earnings Per Share (EPS)	25.29
EBITDA	113.19
Effective Tax Rate (%)	-0.43

Particulars	MAR 2021 (Values in Cr)
Revenue	392.52
Operating Expense	407.32
Net Profit	-12.61
Net Profit Margin (%)	-3.21
Earnings Per Share (EPS)	-5.04
EBITDA	20.41
Effective Tax Rate (%)	-1.61

Particulars	MAR 2020 (Values in Cr)
Revenue	367.45
Operating Expense	386.56
Net Profit	64.46
Net Profit Margin (%)	17.54
Earnings Per Share (EPS)	26.90
EBITDA	107.22
Effective Tax Rate (%)	0.32

Particulars	MAR 2024 (Values in Cr)
Book Value / Share	6.70
ROE %	49.77
ROCE %	33.46
Total Debt to Total Equity	0.00
EBITDA Margin	13.14

Particulars	MAR 2023 (Values in Cr)
Book Value / Share	-10.07
ROE %	0.00
ROCE %	0.00
Total Debt to Total Equity	0.00
EBITDA Margin	5.43

Particulars	MAR 2022 (Values in Cr)
Book Value / Share	-7.27
ROE %	306.03
ROCE %	16.14
Total Debt to Total Equity	0.00
EBITDA Margin	7.33

Particulars	MAR 2021 (Values in Cr)
Book Value / Share	-62.46
ROE %	0.00
ROCE %	0.00
Total Debt to Total Equity	0.00
EBITDA Margin	5.20

Particulars	MAR 2020 (Values in Cr)
Book Value / Share	-57.39
ROE %	36.16
ROCE %	7.96
Total Debt to Total Equity	0.00
EBITDA Margin	6.67

Particulars	MAR 2024 (Values in Cr)
Book Value / Share	6.70
ROE %	38.26
ROCE %	32.14
Total Debt to Total Equity	8.98
EBITDA Margin	12.68

Particulars	MAR 2023 (Values in Cr)
Book Value / Share	-2.26
ROE %	0.00
ROCE %	0.00
Total Debt to Total Equity	0.00
EBITDA Margin	4.70

Particulars	MAR 2022 (Values in Cr)
Book Value / Share	0.57
ROE %	37.03
ROCE %	17.45
Total Debt to Total Equity	0.00
EBITDA Margin	7.26

Particulars	MAR 2021 (Values in Cr)
Book Value / Share	-52.23
ROE %	0.00
ROCE %	0.00
Total Debt to Total Equity	0.00
EBITDA Margin	5.20

Particulars	MAR 2020 (Values in Cr)
Book Value / Share	-47.14
ROE %	48.96
ROCE %	8.54
Total Debt to Total Equity	0.00
EBITDA Margin	6.64

Particulars	MAR 2024 (Values in Cr)
Cash & Short Term Investments	5.89
Total Assets	343.49
Total Liabilities	343.49
Total Equity	27.94
Share Outstanding	32745498
Price to Book Ratio	21.77
Return on Assets (%)	16.29
Return on Capital (%)	40.58

Particulars	MAR 2023 (Values in Cr)
Cash & Short Term Investments	3.93
Total Assets	303.52
Total Liabilities	303.52
Total Equity	-32.81
Share Outstanding	32705498
Price to Book Ratio	-16.51
Return on Assets (%)	-3.42
Return on Capital (%)	-33.19

Particulars	MAR 2022 (Values in Cr)
Cash & Short Term Investments	25.31
Total Assets	352.54
Total Liabilities	352.54
Total Equity	-23.41
Share Outstanding	32665498
Price to Book Ratio	149.12
Return on Assets (%)	23.10
Return on Capital (%)	186.85

Particulars	MAR 2021 (Values in Cr)
Cash & Short Term Investments	11.70
Total Assets	289.17
Total Liabilities	289.17
Total Equity	-156.24
Share Outstanding	25015117
Price to Book Ratio	-1.59
Return on Assets (%)	-4.35
Return on Capital (%)	-301.65

Particulars	MAR 2020 (Values in Cr)
Cash & Short Term Investments	16.69
Total Assets	278.69
Total Liabilities	278.69
Total Equity	-143.45
Share Outstanding	24995117
Price to Book Ratio	-0.39
Return on Assets (%)	23.13
Return on Capital (%)	-339.49

Particulars	MAR 2024 (Values in Cr)
Cash & Short Term Investments	5.89
Total Assets	343.49
Total Liabilities	343.49
Total Equity	27.94
Share Outstanding	32745498
Price to Book Ratio	21.77
Return on Assets (%)	8.85
Return on Capital (%)	22.05

Particulars	MAR 2023 (Values in Cr)
Cash & Short Term Investments	3.89
Total Assets	301.89
Total Liabilities	301.89
Total Equity	-7.25
Share Outstanding	32705498
Price to Book Ratio	-16.51
Return on Assets (%)	-3.44
Return on Capital (%)	-18.28

Particulars	MAR 2022 (Values in Cr)
Cash & Short Term Investments	25.27
Total Assets	351.00
Total Liabilities	351.00
Total Equity	2.18
Share Outstanding	32665498
Price to Book Ratio	149.12
Return on Assets (%)	23.21
Return on Capital (%)	117.72

Particulars	MAR 2021 (Values in Cr)
Cash & Short Term Investments	11.66
Total Assets	287.60
Total Liabilities	287.60
Total Equity	-130.65
Share Outstanding	25015117
Price to Book Ratio	-1.59
Return on Assets (%)	-4.38
Return on Capital (%)	-42.35

Particulars	MAR 2020 (Values in Cr)
Cash & Short Term Investments	16.65
Total Assets	277.16
Total Liabilities	277.16
Total Equity	-117.83
Share Outstanding	24995117
Price to Book Ratio	-0.39
Return on Assets (%)	23.25
Return on Capital (%)	971.77

Particulars	MAR 2024 (Values in Cr)
Net Income	56.33
Cash from Operations	4.16
Cash from Investing	-16.62
Cash from Financing	14.55
Net change in Cash	1.90
Free Cash Flow	21.58

Particulars	MAR 2023 (Values in Cr)
Net Income	-10.28
Cash from Operations	19.97
Cash from Investing	-8.83
Cash from Financing	-31.99
Net change in Cash	-21.03
Free Cash Flow	32.59

Particulars	MAR 2022 (Values in Cr)
Net Income	81.12
Cash from Operations	40.68
Cash from Investing	0.58
Cash from Financing	-28.58
Net change in Cash	12.52
Free Cash Flow	50.34

Particulars	MAR 2021 (Values in Cr)
Net Income	-12.40
Cash from Operations	17.81
Cash from Investing	8.04
Cash from Financing	-17.38
Net change in Cash	7.34
Free Cash Flow	22.24

Particulars	MAR 2020 (Values in Cr)
Net Income	64.67
Cash from Operations	44.16
Cash from Investing	63.66
Cash from Financing	-107.87
Net change in Cash	-0.07
Free Cash Flow	51.99

Particulars	MAR 2024 (Values in Cr)
Net Income	30.78
Cash from Operations	4.19
Cash from Investing	-16.62
Cash from Financing	14.55
Net change in Cash	1.94
Free Cash Flow	21.62

Particulars	MAR 2023 (Values in Cr)
Net Income	-10.28
Cash from Operations	19.97
Cash from Investing	-8.83
Cash from Financing	-31.99
Net change in Cash	-21.03
Free Cash Flow	32.59

Particulars	MAR 2022 (Values in Cr)
Net Income	81.12
Cash from Operations	40.68
Cash from Investing	0.58
Cash from Financing	-28.58
Net change in Cash	12.52
Free Cash Flow	50.34

Particulars	MAR 2021 (Values in Cr)
Net Income	-12.40
Cash from Operations	17.81
Cash from Investing	8.04
Cash from Financing	-17.38
Net change in Cash	7.34
Free Cash Flow	22.24

Particulars	MAR 2020 (Values in Cr)
Net Income	64.67
Cash from Operations	44.15
Cash from Investing	63.66
Cash from Financing	-107.87
Net change in Cash	-0.08
Free Cash Flow	51.98

Company Name	Price	P/E	P/B	Market Cap	52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L	35.26	18.96	1.92	270.21	34.11 / 77.70
BLISS GVS PHARMA LTD	117.60	15.41	1.22	1239.15	92.25 / 184.95
CIPLA LTD	1508.70	24.42	4.29	121844.87	1317.60 / 1702.00
FERMENTA BIOTECH LIMITED	245.70	20.36	2.49	723.12	145.00 / 449.00

Company Name	Price	P/E	P/B	Market Cap	52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L	35.26	21.24	5.99	270.21	34.11 / 77.70
AMRUTAJAN HEALTH LTD	603.65	35.38	5.86	1745.19	548.05 / 861.40
ASTRAZENECA PHARMA IND LT	7928.65	118.25	29.17	19821.63	4050.15 / 8139.85
BLISS GVS PHARMA LTD	117.60	15.27	1.20	1239.15	92.25 / 184.95

Technicals

EMA & SMA
Resistance and Support
Price Change Analysis

Bullish Moving Averages -

Bearish Moving Averages -

5 Days 209.70
26 Days 206.30
10 Days 204.40
50 Days 217.40
12 Days 203.50
100 Days 226.50
20 Days 203.90
200 Days 214.90

214.50
PIVOT

First Resistance	229.37
Second Resistance	239.57
Third Resistance	254.44

First Support	204.30
Second Support	189.43
Third Support	179.23

RSI	56.35
MACD	-2.79
Commodity Channel Index (CCI)	95.45

ADX	16.47
Williams % R	-7.82

Wanbury Limited Future

Future: Price

25 May

0 100 200 300 400 500 600

Discount/Premium

25 May

0 1 2 3 4 5 6 7

Active Calls

25 May

0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul

0 500 1000 1500 2000 2500

Stock Holding

View Live Stock Screeners

Holding

Public

59.39 Promoter Holdings

39.76 FII

0.84 DII

0.0 Promoter Shares(Pledge Percentage)

76.74

Name	Category	Shares	Shares%
Expert Chemicals (india) Pvt Ltd	Shareholding of Promoter and Promoter Group	1.0005561E7	30.53
Kingsbury Investments Inc.	Shareholding of Promoter and Promoter Group	3024000.0	9.23
Authum Investment And Infrastructure Limited	Public Shareholding	768000.0	2.34
Suresh Bhatia	Public Shareholding	721230.0	2.2
Magnum Equifin Private Limited	Public Shareholding	500100.0	1.53
East Eight Six Advisors Llp	Public Shareholding	452538.0	1.38
Surbhi Investments And Trading Company Private Limited	Public Shareholding	450000.0	1.37
Suresh Bhatia(huf)	Public Shareholding	352421.0	1.08
Milan Manharkant Ganatra	Public Shareholding	343915.0	1.05

Wanbury share result highlights

The Wanbury share price has experienced fluctuations following the company’s recent financial results. Wanbury reported moderate revenue growth, driven by strong demand in the pharmaceutical sector. However, profit margins were impacted by rising input costs and operational expenses. The company’s focus on expanding its product portfolio and enhancing its manufacturing capabilities contributed positively to overall revenue. Despite these efforts, net profit remained under pressure, reflecting the challenges faced in maintaining profitability. Nevertheless, Wanbury’s strategic initiatives in research and development have positioned it for future growth, keeping the Wanbury share price stable, with cautious optimism from investors about the company’s long-term performance.

Wanbury share annual reports

Wanbury’s annual reports provide a comprehensive overview of the company’s financial performance, which directly impacts the Wanbury share price. The reports highlight key metrics such as revenue growth, operational efficiency, and cost management. They also outline the company’s strategic initiatives, including investments in research and development, which are essential for future growth. Investors use these reports to assess Wanbury’s financial stability and long-term potential. The annual reports are crucial for understanding the company’s progress and the factors that drive the Wanbury share price, offering valuable insights into its operational and financial outlook.

Wanbury share dividend

Wanbury has not been a regular dividend-paying company in recent years due to its focus on reinvesting profits into business expansion and research initiatives. The company’s primary goal has been to strengthen its financial position and improve operational efficiencies. As a result, dividend payments have been limited, which may not attract income-focused investors. However, as Wanbury continues to stabilise its financial performance, future dividend payouts may become a possibility. This strategic reinvestment has helped support the long-term stability of the Wanbury share price.

About Wanbury Limited

Learn More About Stocks

India proposes 12% safeguard duty on flat steel imports for 200 days

India’s DGTR has proposed a 12% safeguard duty on flat steel imports for 200 days, affecting major steel stocks. JSW Steel share price and Tata Steel share price will be under watch as Nifty Metal Index gains 10% in March 2025.

19 Mar, 2025 | 2 Min. read

Premier Explosives Secures Rs 189 Million Defence Export Order

Premier Explosives secures a Rs 189 million export order for defence explosives, boosting its global presence. Premier Explosives share price likely to be in focus.

19 Mar, 2025 | 2 Min. read

Delhi’s Power Demand to Cross Record 9,000 MW This Summer

Delhi’s power demand is set to exceed 9,000 MW for the first time. Renewable energy sources will support supply. Solar Energy Corporation of India share price in focus.

19 Mar, 2025 | 2 Min. read

G R Infraprojects Secures NHAI Project Worth Rs 42.63 Billion

G R Infraprojects receives a letter of award from NHAI for a project worth Rs 42.63 billion. G R Infraprojects share price likely to remain in focus.

19 Mar, 2025 | 2 Min. read

Moody’s Affirms IndusInd Bank Ratings, Places BCA on Review for Downgrade

Moody’s has affirmed IndusInd Bank’s Ba1 rating with a stable outlook but placed its Baseline Credit Assessment (BCA) on review for downgrade due to risk concerns.

18 Mar, 2025 | 3 Min. read

Manappuram Finance Board to Consider Fundraising Proposals on March 20

Manappuram Finance’s board to meet on March 20 to discuss fundraising through equity shares, warrants, or debt securities. Shares remain in focus amid stake sale reports.

18 Mar, 2025 | 3 Min. read

Tata Motors Incorporates Digital.AI Labs to Expand in IT Sector

Tata Motors has launched Tata Motors Digital.AI Labs Limited, a wholly owned subsidiary focused on IT and digital solutions. Tata Motors share price remains in focus.

18 Mar, 2025 | 3 Min. read

IRCON Wins Rs.285 Crore Order in Meghalaya Secretariat Project

IRCON International secures a Rs.285 crore share in a Rs.1,096.17 crore EPC contract for a new Secretariat Complex in Meghalaya. Project completion is set for 36 months.

18 Mar, 2025 | 3 Min. read

Zydus Life Gets Final USFDA Approval for Eluxadoline Tablets

Zydus Lifesciences Ltd. receives final USFDA approval for Eluxadoline Tablets, 75 mg and 100 mg, securing 180-day shared exclusivity in the US market.

17 Mar, 2025 | 2 Min. read

Galaxy Surfactants Declares ₹18 Per Share Interim Dividend for FY25

Galaxy Surfactants announces an interim dividend of ₹18 per equity share for FY25. The record date is March 20, 2025, with payment to be made within 30 days.

17 Mar, 2025 | 2 Min. read

We have something for everyone

Explore More Investment Options

Start Investing

Stocks

Secure and enhance your financial future today

Invest

IPOs

Your gateway to future financial opportunities

Invest

MTF

Explore Buy Now Pay Later and boost your capital by up to 4x

Invest

US Stocks

Discover opportunities to invest in elite FAANG stocks

Invest

Frequently Asked Questions

What is the Share Price of Wanbury Ltd?

Answer Field: The share price of Wanbury Ltd for NSE is ₹ 226.21 and for BSE is ₹ 226.9.

What is the Market Cap of Wanbury Ltd?

Answer Field: The market cap of Wanbury Ltd for NSE is ₹ 7,40.73 Cr. and for BSE is ₹ 7,42.99 Cr. as of now.

What is the 52 Week High and Low of Wanbury Ltd?

Answer Field: The 52 Week High and Low of Wanbury Ltd for NSE is ₹ 323.53 and ₹ 123.00 and for BSE is ₹ 325.00 and ₹ 122.10.

How to Buy Wanbury Ltd share?

Answer Field: You can trade in Wanbury Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Wanbury Ltd?

Answer Field: The 1 year returns on the stock has been 67.94%.

What is the Current Share Price of Wanbury Ltd?

Answer Field: Wanbury Ltd share price is for NSE ₹ 226.21 & for BSE ₹ 226.9 as on Mar 19 2025 03:30 PM.

What is the Market Cap of Wanbury Ltd Share?

Answer Field: The market cap of Wanbury Ltd for NSE ₹ 7,40.73 & for BSE ₹ 7,42.99 as on Mar 19 2025 03:30 PM.

What is the P/E Ratio of Wanbury Ltd Share?

Answer Field: As on Mar 19 2025 03:30 PM the price-to-earnings (PE) ratio for Wanbury Ltd share is 38.31.

What is the PB ratio of Wanbury Ltd Share?

Answer Field: As on Mar 19 2025 03:30 PM, the price-to-book (PB) ratio for Wanbury Ltd share is 11.82.

How to Buy Wanbury Ltd Share?

Answer Field: You can trade in Wanbury Ltd shares with Bajaj Broking by opening a demat accountopens in a new tab.

How to Buy Wanbury Ltd Share on Bajaj Broking App?

Answer Field

To buy Wanbury Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Wanbury Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

Popular FAQs

Who is the CEO of Wanbury?

As of the latest available information, the CEO of Wanbury is Mr. Arvind Doshi. He is responsible for overseeing the company’s strategic direction and overall operations, which directly impact the Wanbury share price. His focus on expanding Wanbury’s product offerings and strengthening its position in the pharmaceutical sector plays a key role in driving the company’s financial performance and long-term growth.

When was Wanbury established?

Wanbury was established in 1990. Since its inception, the company has grown to become a prominent player in the pharmaceutical industry, specialising in active pharmaceutical ingredients and formulations. Over the years, Wanbury has expanded its operations, contributing to its strong market presence. This long-standing history has had a positive impact on the Wanbury share price, reflecting the company’s stability and growth potential.

What factors influence the Wanbury share price?

Several factors influence the Wanbury share price, including the company’s financial performance, revenue growth, and profitability margins. External factors such as regulatory changes, demand for pharmaceutical products, and market competition also play a significant role. Additionally, investor sentiment regarding Wanbury’s ability to manage costs, expand its product portfolio, and maintain profitability affects the share price movement.

Is Wanbury debt free?

Wanbury is not entirely debt-free, but it maintains a manageable level of debt. The company’s focus on effective debt management ensures that its financial obligations do not negatively impact its profitability. This controlled debt structure contributes to the overall stability of the Wanbury share price, as investors generally prefer companies with a balanced approach to managing liabilities and sustaining long-term growth.

How has the Wanbury share price performed over the past year?

Over the past year, the Wanbury share price has experienced moderate fluctuations, reflecting the company’s financial performance and market conditions. While the company has seen revenue growth, challenges related to rising input costs and operational expenses have impacted profitability. Despite these hurdles, the Wanbury share price has remained relatively stable, with investors maintaining cautious optimism about the company’s future growth potential.

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Scan to download

Download from App Store

Download from Play Store

9 lakh+ Users

4.3+ App Rating

4 Languages

₹4300+ Cr MTF Book

Open Demat Account

Divine Hira Jewellers IPO is Open!

Open a Free Demat Account

Trade Now, Pay Later with up to 4x

Track Market Movers Instantly

Wanbury Limited Share Price

Wanbury Limited Share Price Update

Wanbury Limited Performance

Day Range

52 Week Range

Wanbury Limited Share Price

Open Price

227.00

Prev. Close

219.17

Volume (Shares)

137965.00

Total traded value

312.35

Upper Circuit

263.00

Lower Circuit

175.33

Wanbury Limited Fundamentals

Wanbury Limited Financials

Revenue

Net income

Technicals

Over 1 Month

11.86

Over 3 Months

-27.89

Over 6 Months

-13.49

Over 1 Year

67.94

Over 3 Years

35.37

Over 5 Years

62.32

Wanbury Limited Future

Future: Price

Discount/Premium

Active Calls

Active Puts

Wanbury Limited Shareholding Pattern

Stock Holding

View Live Stock Screeners

Holding

Public

59.39

Promoter Holdings

39.76

FII

0.84

DII

0.0

Promoter Shares(Pledge Percentage)

76.74

Holding %

Pledges % of promoter shares %

MF Holding %

FII Holding %

Wanbury Limited

Wanbury share result highlights

Wanbury share annual reports

Wanbury share dividend

About Wanbury Limited

Companies Owned by Wanbury Limited

Learn More About Stocks

India proposes 12% safeguard duty on flat steel imports for 200 days

Premier Explosives Secures Rs 189 Million Defence Export Order

Delhi’s Power Demand to Cross Record 9,000 MW This Summer

G R Infraprojects Secures NHAI Project Worth Rs 42.63 Billion

Explore More Investment Options

Stocks

IPOs

MTF

US Stocks

Frequently Asked Questions

What is the Share Price of Wanbury Ltd?